The pathogenesis of lipodermatosclerosis: Facts, uncertainties and theories

Journal of the European Academy of Dermatology and Venereology

Volumn 9, Issue 3, 1997, Pages 209-214

  Naschitz, Jochanan E ^a   Yeshurun, Daniel ^a   Misselevich, Ines ^a   Boss, Jochanan H ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Fasciitis; Lipodermatosclerosis; Penniculitis; Venous insufficiency

Indexed keywords

EOSINOPHILIC FASCIITIS; HUMAN; HYPERTENSION; LIPODERMATOSCLEROSIS; MICROANGIOPATHY; PANNICULITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VEIN INSUFFICIENCY;

EID: 0031458243     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(97)00088-3     Document Type: Review

References (52)

1. Franzeck UK, Haselbach P, Speiser D, Bollinger A. Microangiopathy of cutaneous blood and lymphatic capillaries in chronic venous insufficiency (CVI). Yale J Biol Med 1993;67:37-46.
2. Huriez C, Legache G, Desmons F. Ulcers de jambes et troubles trophiques d'origine veineuse (donnés tirées de l'étude d'un millier d'ulcereux hospitalisés). Rev Pract 1955;5:2703-2721.
3. Browse NL, Jarrett PEM, Morland M, Burrand K. Treatment of liposclerosis of the leg with fibrinolytic enhancement, a preliminary report. Br Med J 1977;3:434-435.
4. Kirsner RS, Pardes JB, Eagelstein WH, Falange V. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol 1993;28:623-627.
5. Naschitz JE, Yeshurun D, Schwartz H, et al. Pathogenesis of lipodermatosclerosis of venous disease: the lesson learned from eosinophilic fasciitis. Cardiovasc Surg 1993;1:524-529.
6. Naschitz JE, Yeshurun D, Zuckerman E, et al. The fasciitis panniculitis syndrome: clinical spectrum and response to cimetidine. Semin Arthritis Rheum 1992;21:211-220.
7. Naschitz JE, Boss JH, Misselevich I, Yeshurun D, Rosner I. The fasciitis-panniculitis syndromes. Clinical and pathological features. Medicine (Baltimore) 1996;75:6-16.
8. McDonagh PF. The microvascular pathophysiology of chronic venous insufficiency. Yale J Biol Med 1993;66:27-36.
9. Luetolf O, Bull RH, Bates DO, Mortimer PS. Capillary underperfusion in chronic venous insufficiency: a cause for leg ulceration? Br J Dermatol 1993;128:249-254.
10. Allen AJ, Wright DII, McCollum CN. Impaired postural vasoconstriction: a contributory cause of oedema in patients with chronic venous insufficiency. Phlebology 1988;3:163-168.
11. Burnand KG, Whimster I, Naidoo A, Browse NL. Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. Br Med J 1982;285:1071-1072.
12. Neumann HAM, van den Broek MJTB. Increased collagen IV layer in the basal membrane area of capillaries in severe chronic venous insufficiency. VASA J Vasc Dis 1991;20:26-29.
13. Wenner A, Leu HJ, Spycher M. Ultrastructural changes of capillaries in chronic venous insufficiency. Exp Cell Biol 1980;48:1-4.
14. Cheatle TR, McMullin GM, Farrah J, Smith PD, Scurr JH. Skin damage in chronic venous insufficiency: does an oxygen diffusion barrier really exist? J R Soc Med 1990;83:493-494.
15. Thomas P, Nash JB, Dormandy JA. White cell accumulation in the dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J 1988;296:1726-1727.
16. Claudy AL, Mirshahi M, Soria C, Soria J. Detection of degraded fibrin and tumor necrosis factor alpha in venous leg ulcers. J Am Acad Dermatol 1991;25:623-627.
17. Higley H, Ksander G, Gerhardt C. Immunocytochemical analysis of growth factor and growth factor responsive cells in chronic venous stasis ulcers. Wounds 1992;4:33-34.
18. Scurr JH, Coleridge-Smith PD. The microcirculation in venous disease. Angiology 1994;45:537-541.
19. Hammond SL, Gomez ER, Coffey JA. Involvement of the lymphatic system in chronic venous insufficiency. In: Bergan J, Yao J, eds. Venous Disorders. Philadelphia: WB Saunders Company, 1991:333-343.
20. Nicolaides AN, Zukowski AG. The value of dynamic venous pressure measurements. World J Surg 1986;10:919-924.
21. Nicolaides AN, Hussein MK, Szendro G, et al. The relation of venous ulceration with ambulatory venous pressure measurements. J Vasc Surg 1993;17:414-419.
22. Caseley-Smith JR, Gaffney RM. Excess plasma proteins as a cause of chronic inflammation and lymphedema: quantitative electron microscopy. J Pathol 1981;133:243-272.
23. Burnand K, Clemenson G, Morland M, Jarrett PE, Browse NL. Venous lipodermatosclerosis: treatment by fibrinolytic enhancement and elastic compression. Br Med J 1980;280:7-11.
24. Caseley-Smith JR, Morgan RG, Pillar NB. Treatment of lymphedema of the arms and legs with 5,6-benzo-α-pyrone. N Engl J Med 1993;329:1158-1163.
25. Coleridge-Smith PD. Pathogenesis of chronic venous insufficiency and possible effects of compression and pentoxifylline. Yale Biol Med 1993;66:47-59.
26. Nehler MR, Moneta GL, Woodard DM, Defrang RD, Harker CT, Taylor LM Jr. Perimalleolar subcutaneous tissue pressure effects of elastic compression stockings. J Vasc Surg 1993;18:783-788.
27. Burnand KG, Clemenson G, Whimster I, Gaunt J, Browse NL. The effect of sustained venous hypertension on the skin capillaries of the canine hind limb. Br J Surg 1982;69:41-44.
28. Naschitz JE, Abineder EG, Yeshurun D. M-mode ultrasonography of pulsating saphenous veins in a patient with severe tricuspid regurgitation. J Cardiovasc Ultrasound 1982;1:333-335.
29. Roszinski S, Koser I, Wilhelm KP, Schmeller W. Oxygenation of the dermis and subcutis in dermatoliposclerosis. VASA J Vasc Dis 1993;22:297-305.
30. Shami SK, Shields DA, Farrah J, Scurr JH, Coleridge-Smith PD. Peripheral nerve function in chronic venous insufficiency. Eur J Vasc Surg 1993;7:195-200.
31. Cantwell AR, Kelso DW, Rowe L. Hypodermitis sclerodermiformis and unusual acid-fast bacteria. Arch Dermatol 1979;115:312-314.
32. Jorizzo JL, White WL, Zanolli MD. Sclerosing panniculitis. Arch Dermatol 1991;115:449-452.
33. Jarrett PE, Burnand K, Morland M, Browse NL. Fibrinolysis and fat necrosis in the lower leg. Br J Surg 1976;280:7-11.
34. Alegre VA, Winkelmann RK, Aliaga A. Lipomembranous changes in chronic panniculitis. J Am Acad Dermatol 1988;19:39-46.
35. Abramson J. Circulatory Diseases of the Limbs: A Primer. New York: Grune and Stratton, 1978:233.
36. Angelides NS, von der Ahe W, Themistocleus P. Comparison of skin and muscle biopsies before and after pentoxiphilline treatment in patients with leg ulcers due to deep venous incompetence. Int Angiol 1991;10:73-76.
37. Su WP, Person JR. Morphea profunda: a new concept and histologic study of 23 cases. Am J Dermatopathol 1981;3:251-260.
38. Falanga V. Localized scleroderma. Med Clin North Am 1989;73:1143-1156.
39. Naschitz JE, Yeshurun D, Shajrawi I, Misselevich I, Boss JH. The fasciitis-panniculitis syndrome in circulatory disorders of the limbs. Int J Angiol 1996;5:149-156.
40. Janin A, Socies G, Devergie A, et al. Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases. Ann Intern Med 1994;120:993-998.
41. Colver GB, Rodger A, Mortimer B, Savin JA. Post-irradiation morphea. Br J Dermatol 1989;12:831-835.
42. Malane MS, Graant-Kleis JM, Feder HM Jr, Luger SW, Neill SM, Hunter JA. Diagnosis of Lyme disease based on dermatologic manifestations. Ann Intern Med 1991;114:490-498.
43. Zuckerman E, Naschitz JE, Yeshurun D, Wellisch G, Shajrawi I, Boss JH. Fasciitis-panniculitis in acute brucellosis. Int J Dermatol 1994;33:57-59.
44. Naschitz JE, Yeshurun D, Zuckerman E, et al. Cancer-associated fasciitis panniculitis. Cancer 1994;73:232-235.
45. Alonzo-Ruiz A, Zea-Mendoza AC, Salazar-Vallinas JM, Rocamora A, Beltran-Gutierrez J. Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma. Semin Arthritis Rheum 1986;15:200-212.
46. Freundlich B, Werth VP, Rook AH, et al. L-Tryptophane ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosis. Ann Intern Med 1990;112:758-762.
47. Boss JH, Sabo E, Shajrawi I, et al. The fasciitis-panniculitis reaction pattern. In: Santoscoy GG, ed. Volume of the XVII World Congress of Anatomic and Clinical Pathology. Bologna: Monduzzi Editore SpA, 1994:551-555.
48. Naschitz JE, Sabo E, Yeshurun D, Gilhar A, Misselevich I, Boss JH. An experimental model of fasciitis-panniculitis. Induction of chronic fibrosing panniculitis in the rat by subcutaneous injections of lipase. Isr J Med Sci 1996;32:1078-1085.
49. Kahaleh BM. Vascular disease in scleroderma: endothelial-T lymphocyte-fibroblast interactions. Rheumatol Clin North Am 1990;16:53-73.
50. Varga J, Jimenez SA. Chemical exposure-induced cutaneous fibrosis. Lessons from 'experiments of nature'. Arch Dermatol 1994;130:97-100.
51. Varga J, Uitto J, Jimenez SA. The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Intern Med 1992;116:140-147.
52. Mehm WJ, Pimsler M, Becker RL. Effect of oxygen on in vitro fibroblast cell proliferation and collagen biosynthesis. J Hyperbaric Med 1988;3:227-223.